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predicted mortality in ARF patients. None of the models pro-Predicting patient outcome from acute renal failure comparing
vided sufficient confidence for the prediction of outcome inthree general severity of illness scoring systems.
individual patients. A high degree of caution must be exertedBackground. A major problem of studies on acute renal
in the application of existing general prognostic models forfailure (ARF) arises from a lack of prognostic tools able to
outcome prediction in ARF patients.express the medical complexity of the syndrome adequately
and to predict patient outcome accurately. Our study was thus
aimed at evaluating the predictive ability of three general prog-
nostic models [version II of the Acute Physiology and Chronic Acute renal failure (ARF) is frequently observed inHealth Evaluation (APACHE II), version II of the Simplified
hospitalized patients and is increasingly prevalent inAcute Physiology Score (SAPS II), and version II of the Mor-
aging populations with multiple chronic comorbidities,tality Probability Model at 24 hours (MPM24 II)] in a prospec-
tive, single-center cohort of patients with ARF in an intermedi- in subjects with severe underlying diseases such as neo-
ate nephrology care unit. plasia or AIDS, and in the intensive care unit (ICU)
Methods. Four hundred twenty-five patients consecutively populations [1].admitted for ARF to the Nephrology and Internal Medicine
Acute renal failure is associated with a high mortality,Department over a five-year period were studied (272 males
and despite the considerable therapeutic progress andand 153 females, median age 71 years, interquartile range 61
to 78, median APACHE II score 23, interquartile range 18 to technological improvement observed over the past few
28). Acute tubular necrosis (ATN) accounted for 68.7% (292 years, the prognosis of the syndrome remains poor [2–6].
out of 425) of patients. Renal replacement therapies (hemodial- A major problem of studies on ARF arises from aysis or continuous hemofiltration) were used in 64% (272 out
lack of prognostic tools able to adequately express theof 425) of ARF patients.
medical complexity of the syndrome [1]. These toolsResults. Observed mortality was 39.1% (166 out of 425).
The mean predicted mortality was 36.2% with APACHE II would be of the utmost importance for an objective risk
(P 5 0.571 vs. observed mortality), 39.3% with SAPS II (P 5 stratification in interventional studies, quality of care eval-
0.232), and 45.1% with MPM24 II (P , 0.0001). Lemeshow- uation, and allocation of health care resources. More-Hosmer goodness-of-fit C and H statistics were 15.67 (P 5
over, no accurate mortality risk estimates are available0.047) and 12.05 (P 5 0.15) with APACHE II, 32.53 (P 5
to the nephrologist as decision-making support in order0.0001), 39.8 (P 5 0.0001) with SAPS II, 21.86 (P 5 0.005),
and 20.24 (P 5 0.009) with MPM24 II, respectively. Areas under to avoid unethical and futile care of ARF patients [7, 8].
the receiver operating characteristic (ROC) curve were 0.75, Acute renal failure-specific prediction models devel-
0.77, and 0.85, respectively. oped in the past were usually derived from single institu-Conclusions. The APACHE II model was a slightly better
tions and more often have been validated in specificcalibrated predictor of group outcome in ARF patients, as
subsets of ARF patients, such as ARF in the ICU, ARFcompared with the SAPS II and MPM24 II outcome prediction
models. The MPM24 II model showed the best discrimination on hemodialysis or on continuous hemofiltration, ARF
capacity, in comparison with both APACHE II and SAPS II following aortic aneurysm or heart surgery, and ARF ex-
models, but it constantly and significantly overestimated mean clusively caused by acute tubular necrosis (ATN) [9–19].
The generalizability of these ARF- or ATN-specific mod-
els to the composite ARF patient cohorts commonlyKey words: scoring systems, acute tubular necrosis, critical care, mor-
tality prediction, prognosis, severity of illness index. followed in nephrology units or in medical wards is there-
fore questionable.Received for publication June 1, 1999
General outcome prediction models are widely usedand in revised form January 13, 2000
Accepted for publication January 30, 2000 in the ICUs [20], but limited information is currently
available concerning their application to ARF patients.Ó 2000 by the International Society of Nephrology
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Data, in fact, are usually retrospective [21], and in most As medical care in Italy is covered by the National
Health System, there was no access restriction to treat-cases, only first- or second-generation models have been
used [12, 16, 22, 23]. ment. Therapeutic agents, as well as RRTs (particularly
for what concurs, such as time of starting, modality, doseOur study was aimed at comparing the ability of three
general prognostic models to predict mortality in ARF and filter membranes) were administered at the discre-
tion of the treating nephrologist. The standard hemodial-patients hospitalized in an intermediate nephrology care
unit. ysis schedule was four hours every other day. Conven-
tional bicarbonate hemodialysis was performed throughTo this purpose, we applied three different models
to a prospective cohort of ARF patients: two recently central venous access by double or triple lumen catheters
(internal jugular or subclavian veins) [29], with an ultra-developed, easily available, third-generation, prognostic
models based on an international cohort of critically ill filtration-controlled delivery system, polymethylmeta-
crylate, ethylvinylalcool or polysulfone hollow fiber fil-patients [version II of the Mortality Probability Model
(MPM II), version II of the Simplified Acute Physiology ters, and heparin as the anticoagulant. The heparin-free
hemodialysis method was used for patients at hemor-Score (SAPS II)], and a standard second-generation
model, the Acute Physiology and Chronic Health Evalu- rhagic risk. Continuous RRTs (CRRTs) were performed
as continuous venovenous hemofiltration with prosta-ation II (APACHE II)] [24–26].
cyclin as the circuit anti-aggregant and with the same
filters as for hemodialysis. Indications for CRRT were
METHODS
represented in most cases by hypotension and/or severe
Study population hemodynamic instability and/or severe fluid overload.
We studied all adults patients admitted with a diagno-
Measurementssis of ARF (community or hospital acquired ARF) to the
intermediate nephrology care unit of the Parma Hospital Data collection. Data collection for each patient in-
cluded all of the demographic and clinical variables nec-during a five-year period (January 1994 through Decem-
ber 1998). ARF was defined as an abrupt decline in renal essary to the outcome prediction models considered, and
it was complete in 425 patients for APACHE II andfunction [27] with a recent rise (24 to 48 h) in the plasma
creatinine values of more than 50% above the baseline SAPS II and in 410 patients for MPM24 II. Survival status
was registered up to the hospital discharge.status in the absence of volume-responsive prerenal sta-
tus; in the case of pre-existing renal disease or known Predictive models. Predicted risk of death was calcu-
lated for APACHE II, SAPS II, and MPM24 II usingrenal insufficiency that had not been dialyzed before
and was not considered to be end-stage renal disease published coefficients and equations on the basis of data
obtained during the first 24 hours after admission.(ESRD), patients were required to demonstrate an in-
crease in serum creatinine levels .1 mg/dL from their The APACHE scoring system in the version II model
consists of three parts: Acute Physiology Score (12 physi-baseline status (acute-on-chronic renal failure) [28]. The
ATN diagnosis was made when no improvement in renal ologic variables measured within 24 hours of admission,
maximum 60 points), Chronic Health Score (premorbidfunction was observed after correction of possible prere-
nal causes, as well as by urinary sediment examination, major organ dysfunction, maximum 5 points), and Age
Score (maximum 6 points) [26]. The range of thesodium fractional excretion, and renal ultrasonography.
In the other ARF patients, etiologic diagnosis was made APACHE II score is from 0 to 71. Hospital mortality
can be predicted in an equation that includes theby angiography or angio-computed tomography scan or
by renal biopsy. APACHE II score, whether the patient had received
emergency surgery, and the diagnostic category of theThe intermediate nephrology care unit is a closed, six-
bed specialty unit for ARF patients that is part of the patient.
The SAPS scoring system in the version II model de-Internal Medicine and Nephrology Department. It has
a bed-to-nurse ratio of 3:1 and is staffed by nephrologists rives the score from 12 physiological variables, age, type
of admission (scheduled surgical, unscheduled surgical, orwith advanced experience in critical care nephrology.
The same nephrologists are also responsible for all con- medical), and three underlying disease variables (AIDS,
metastatic cancer, and hematologic malignancy) [25].sultations in other wards and ICUs in cases of possible
ARF, as well as for the renal replacement therapies The resulting SAPS II score is then entered into a pub-
lished mathematical formula in which the solution gives(RRTs) applied to patients hospitalized in the hospital
ICUs. All patients hospitalized with ARF were referred the numerical value of the predicted hospital mortality.
The MPM version II model uses physiologic variables,to the unit if they were not on mechanical ventilation at
the time of the possible referral. Thus, the only exclusion chronic diagnosis, acute diagnosis, type of admission, age,
use of cardiopulmonary resuscitation, and use of me-criterion from the study was ARF on mechanical ventila-
tion during the entire course of hospital stay. chanical ventilation to estimate the probability of patient
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mortality at sequential time points: admission (MPM0 II), correctly ranked. The curve is constructed by varying the
24 (MPM24 II) [24], 48 (MPM48 II), and 72 (MPM72 II) cut point used to determine the values of the predicted
hours after admission [30]. The MPM24 II model can be probability to be considered correctly classified, and then
compared with both SAPS II and APACHE II. In fact, plotting the resulting true positive and false positive
all three models determine their scores by using the worst rates. If a model could perfectly discriminate, the curve
level for physiologic variable values measured during the would pass through the point (0, 1) on the grid unit.
first 24 hours after admission. Thus, the closer an ROC curve comes to this ideal point,
Accuracy of outcome prediction. The accuracy of out- the better is its discriminant ability. A model with no
come prediction was assessed in terms of discrimination discriminant ability produces a curve that follows the
and calibration, according to recent recommendations diagonal of the grid. As a rule, the bigger the area, the
[20]. Calibration, that is, the accuracy of the risk predic- better the discriminatory capacity of the model: it is
tions by the model or ability of a model to describe the generally thought that an area under the ROC curve of
mortality pattern in the population, was evaluated by $0.7 is acceptable, while $0.8 is good, and $0.9 is excel-
the difference between observed and expected mortality, lent [20]. The areas under the ROC curve and its confi-
by calibration curves, and by the Lemeshow-Hosmer C dence limits were obtained by the Mann–Whitney two-
and H statistics [31, 32]. Observed and predicted mortal- sample U statistic and its standard error [33]. The method
ity probabilities were compared by the Wilcoxon signed proposed by DeLong, DeLong, and Clarke-Pearson was
rank test. Calibration curves are based on linear re- employed to test whether the difference between the
gression analysis, in which the observed death rates are ROC areas was statistically significant [34]. Data were
plotted against predicted death rates stratified by 10% recorded at admission on preprinted forms by experi-
predicted risk ranges. The R2 value represents the pro- enced medical personnel involved in the study. The Ac-
portion of variation of the dependent variable (observed cess ’97 database (Microsoft, Seattle, WA, USA) was
death rate) that is predicted from the independent vari- used for final data recording and processing. Data are
able (predicted death rate). An R2 value of 1.0 indicates presented as median and interquartile range, unless oth-
that all plotted points lie on a straight line and that the
erwise specified. Data analysis and statistics were per-
independent variable is able to predict the dependent
formed by the Prism software, version 2.01 (GraphPadvariable with 100% certainty. If the predictive model fits
Software Inc., San Diego, CA, USA), and the STATAthe study data well (that is, it calibrates), the plotted points
statistical software, release 5.0 (StataCorp., College Sta-(the predicted and observed death rates) will lie approxi-
tion, TX, USA).mately on a 458 line (slope 5 1), with intercept 5 0. An
upward shift of the line implies that the predictive model
underestimates the actual rates, while a downward shift RESULTS
represents an overestimation of actual mortality. Chi- During the study period, ARF diagnosis was made in
square C and H statistics of Lemeshow and Hosmer were
461 patients in the hospital. As the study period was a
also calculated [31, 32]. These tests evaluated the degree
total of five years and our hospital was the ARF referralof correspondence between a model’s estimate probabil-
center for an average population of 450,000 inhabitants,ities of mortality and the actual mortality experience
the estimated incidence rate of ARF was 20.48 perof patients over groups spanning the entire range of
100,000 person-years (95% CI, 18.6 to 22.4). Of the 461probabilities. The test compared the predicted number
patients with a diagnosis of ARF during the study period,of patients who died and who survived with the actual
36 were not included in the study. Twenty-five patientsnumber of patients who died and who survived, within
were excluded as they needed mechanical ventilation in10 groups defined by the predicted risk of mortality.
the hospital ICUs during the entire course of their ARFPatients were stratified by deciles of the estimated proba-
or until death. This subgroup of ARF patients was fol-bilities for the C-test and in decines for the H-test. A
lowed by intensivists with the nephrologists as consul-high P value obtained in the test suggested a good cali-
tants. Eleven patients with ARF who were not on me-bration, and a small P indicated a poor calibration of
chanical ventilation could not be transferred to our unitthe model.
for several reasons (death before referral in 3 cases, bedDiscrimination, that is, the ability to discriminate be-
not available in 2 cases, follow-up in other wards in 5tween patients who live and those who die, was evaluated
cases). The study population thus consisted of 425 sub-by the receiver operating characteristic (ROC) curve and
jects with ARF of different etiologies who representedthe area under the ROC curve [33]. The area under the
92% (425 out of 461) of all patients hospitalized forROC curve is a measure of the overall discriminatory
ARF during the study period and 97% of the eligiblepower of the prognostic variable, and it measures the
population (425 out of 436 ARF patients not on mechani-probability that in randomly paired dead and surviving
patients, the predicted probability of the model will be cal ventilation at the time of possible referral to our unit).
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Table 3. Observed and predicted mortality in the acure renal failureTable 1. Etiology of acute renal failure
cohort and in the acute tubular necrosis subgroup
Acute renal failure N 5 425
Acute renal failure Acute tubular necrosis
Acute tubular necrosis 292 (69%) (N 5 425) (N 5 292)
Glomerulonephritis 17 (4%)
Vasculitis 10 (2.3%) Observed mortality 39.1% (166/425) 44.2% (129/292)
Predicted mortalityAcute interstitial nephritis 17 (4%)
Multiple myeloma 17 (4%) APACHE II 36.2% 40.3%
SAPS II 39.3% 43.1%Vasculara 30 (7.1%)
Obstructive 42 (9.9%) MPM24II 45.1%b 48.4%a
aIncludes atheroembolic disease, renal artery and/or aortic thrombosis or dis- aP , 0.001, bP , 0.0001 vs. observed mortality, Wilcoxon signed rank test
section, renal vein thrombosis
below the diagonal identity line (predicted 5 observed)
Table 2. Demographic and clinical data of the acute renal failure for a large portion of the range of stratified predicted risk.cohort and of the acute tubular necrosis subgroup
That is, the model significantly overestimated mortality
Acute renal Acute tubular over the entire range of patient risk. The APACHE II
failure necrosis
calibration curve was closer to the line of perfect pre-(N 5 425) (N 5 292)
dicting ability. For the ARF cohort, Lemeshow-HosmerAge years 71 (61–78) 72 (62–80)
C and H statistics are reported in Table 4. ROCs areSex 253 M (65%) 186 M (67%)
137 F (35%) 96 F (33%) shown in Figure 2. In the ARF patient, cohort areas
Location under the ROC curve were 0.75, 0.77, and 0.85, respec-Emergency room 18 (4.2%) 12 (4.1%)
tively (P 5 0.0003 vs. APACHE II, P 5 0.00008 vs.Medical wards 260 (61.2%) 169 (57.9%)
Surgical wards 70 (16.5%) 49 (16.8%) SAPS II). In the ATN subgroup, 0.76, 0.76, and 0.84 (P 5
Surgical ICUsa 77 (18.1%) 62 (21.1%) 0.01 vs. APACHE II, P 5 0.008 vs. SAPS II). Table 5Serum creatinine mg/dL 5.3 (3.3–7.1) 4.6 (3.1–6.3)
and Table 6 show the predictive performance of the threeBlood urea nitrogen mg/dL 81 (60–115) 81 (59–115)
APACHE II Score 23 (18–28) 24 (19–31) prognostic models as applied to the subgroup of ARF
Renal replac. therapies 272/425 (64.1%) 189/292 (64.7%) patients not transferred to our unit from an ICU settingHemodialysis only 215/425 (50.6%) 140/292 (47.9%)
(348 subjects, 216 males, 132 females, median age 72 years,CVVH onlyb 44/425 (10.3%) 38/292 (13%)
CVVH 1 hemodialysis 13/425 (3.1%) 11/292 (3.8%) interquartile range 62.5 to 79.0; median APACHE II
Continuous variables are reported as median (interquartile range). score 24, interquartile range 18 to 29; serum creatinine
aIncludes trauma ICU, postoperative ICU, and heart surgery ICU 5.6 mg/dL, interquartile range 3.5 to 7.4; blood ureabContinuous venovenous hemofiltration
nitrogen 82.2, interquartile range 60.1 to 118.4), and to
the subgroup of ARF patients who needed RRT (272
subjects, 163 males, 109 females, median age 72 years,
The etiology of ARF is shown in Table 1. In most interquartile range 62.5 to 77.5; median APACHE II
cases (292 patients out of 425, 69%), it was represented score 25, interquartile range 20 to 30; serum creatinine
by ATN. The patients’ demographic and clinical data 5.9, interquartile range 4.2 to 7.9; blood urea nitrogen
are illustrated in Table 2. Data concerning the ATN 93.5, interquartile range 68 to 127). Again, the mean
subgroup are presented separately. Mortality data (ob- predicted mortality was significantly overestimated by
served vs. predicted mortality) for the ARF cohort and MPM24 II. APACHE II was less well calibrated in the
the ATN subgroup are shown in Table 3. MPM24 II two subgroups of ARF patients than it was in the entire
significantly overestimated the mean predicted mortality ARF cohort or in the ATN subgroup, while calibration
in both the ARF cohort and the ATN subgroup. Calibra- was slightly better for SAPS II and for MPM24 II (in the
tion curves for the three models are illustrated in Figure 1. subgroup of ARF patients who needed RRT), particu-
The curves demonstrated that, in general, the proportion larly if the C statistic was considered. Discrimination
of patients who died increased in accordance with the capacity of the three models as applied in the two sub-
increase in risk of in-hospital mortality predicted by the group of ARF patients was not improved, as compared
three prognostic models. In the case of the ARF cohort, with that documented in both the entire cohort of ARF
patients and in the ATN subgroup. MPM24 II had thethe observed mortality for MPM24 II was significantly
c
Fig. 1. Calibration curves for (A) APACHE II (n), (B) SAPS II (s), and (C ) MPM24 II (e), constructed by plotting observed death rate against
predicted death rate stratified by 10% risk ranges. For any decision criterion, the true positive rate is the percentage of patients predicted to die
from those who actually died. The false positive rate is the percentage of patients predicted to die from those who actually survived. ARF cohort
data are in the left column, ATN subgroup in the right column.
Fiaccadori et al: Outcome prediction in ARF 287
Fiaccadori et al: Outcome prediction in ARF288
Table 4. Calibration indices (Lemeshow-Hosmer C and H statistics) of the ARF patient cohort and the ATN patient subgroup
ARF Cohort (N 5 425) ATN Subgroup (N 5 292)
C test H test C test H test
(p value) (P Value) (P value) (P value)
APACHE II 15.67 (0.047) 12.05 (0.15) 4.13 (0.84) 9.66 (0.29)
SAPS II 32.53 (0.0001) 39.8 (0.0001) 36.71 (0.0001) 31.2 (0.0001)
MPM24 II 21.86 (0.005) 20.24 (0.009) 9.6 (0.29) 11.56 (0.17)
Table 5. Observed and predicted mortality in the ARF subgroup very unlikely that the selection of the patients could have
of patients not referred from an ICU setting, and in the ARF seriously biased our results.
subgroup of patients who needed renal replacement therapies
The overall predictive ability of the models we have
ARF patients not ARF patients who considered in the present study was not very satisfying, and
referred from an needed renal
moreover, it was not uniform over the several subgroups ofICU setting replacement therapy
(N 5 348) (N 5 272) ARF patients considered. In fact, while APACHE II
had an acceptable calibration in the entire ARF patientObserved mortality 40.8% (142/348) 49.3% (134/272)
Predicted mortality cohort and in the ATN subgroup, the model-predictive
APACHE II 36.4% 40.5%b capacity worsened when it was applied to the subgroup
SAPS II 42.3% 47.1%
of patients who needed RRT. In most cases, SAPS IIMPM24 II 47.3%c 53.6%a
did not calibrate nor discriminate well, even despite theaP , 0.05, bP , 0.01, cP , 0.001 vs. observed mortality, Wilcoxon signed rank
test fact that the predicted mortality by the model was the
closest to the observed value. Finally, despite having an
acceptable receiver ROC area, MPM24 II did not cali-
brate well, as it constantly and significantly overesti-
higher ROC area value, that is, a better discriminating mated the in-hospital mortality rate in the ARF patient
capacity. cohort and in the other subgroups of ARF patients.
Many factors could have introduced limitations in the
applicability of general models to ARF patients consid-DISCUSSION
ered in the present study. These factors are linked to
In this study, to our knowledge for the first time, the both the model’s characteristics and particularity of the
predictive accuracy of two third-generation models for syndrome.
outcome prediction applied to a representative and con- First, there are well-known factors not accounted for
sistent population of ARF patients was prospectively in the prognostic models that can have some impact on
compared with that of the currently most widely used patient’s outcome even in general ICUs, such as number
model, APACHE II. Moreover, our study allowed the and type of comorbidities, disparities in technical and
performance of those same models to be analyzed in therapeutic resources available in the ICU, the type of
clinically relevant subgroups of patients with ARF. ICU (open vs. closed), organization (bed-to-nurse ratio),
Our study population can be considered representa- and differences in medical staffing level [20].
tive of the ARF patient populations not on mechanical Second, as many patients in our study (77 out of 425)
ventilation who are usually followed in nephrology units. were referred to our nephrology unit from an ICU set-
The incidence rate data for ARF in the present study ting, a possible limitation could result from a failure in
(20.49 per 100,000 person-years; 95% CI, 18.6 to 22.4) applying the scoring systems to these patients in the first
are quite similar and are even higher compared with 24 hours after hospitalization in the ICU. Thus, at least
those presented in other studies from Europe: 17.2 per from a theoretical point of view, in patients transferred
100,000 person-years [35], 18.5 per 100,000 person-years from an ICU setting, the calculations should have been
(abstract; McGregor et al, XXIX Congr EDTA-ERA, done on the basis of data collected on the day of admis-
1992, p 54), and particularly to the incidence rate of 16.3 sion to that ICU rather than to the nephrology unit. In
per 100,000 person-years documented in a recent study fact, the predictive models we have used were designed
from Spain [36]. The latter study was based on similar for an ICU population with measurements to be derived
diagnostic criteria for ARF and was done within a similar during the first 24 hours of admission to the ICU. How-
health system. Moreover, since the vast majority of eligi- ever, the aim of this study was to demonstrate the use-
ble patients were included in the study and since demo- fulness of the scoring systems at the time the nephrologist
graphic and clinical characteristics of patients eligible sees ARF patients in the nephrology ward, and at that
point must decide, for instance, whether to start thebut not included in our study were not different, it is
Fiaccadori et al: Outcome prediction in ARF 289
Fig. 2. Receiver operator characteristic (ROC)
curves and areas for APACHE II (m), SAPS
II (s), and MPM24 II (e). (A) Acute renal
failure (ARF) cohort data. APACHE II ROC
area 5 0.75 (95% CI, 0.70 to 0.80), N 5 425;
SAPS II ROC area 5 0.77 (95% CI, 0.72 to
0.81), N 5 425; MPM24 II ROC area 5 0.85
(95% CI, 0.81 to 0.88), N 5 410. (B) Acute
tubular necrosis (ATN) subgroup cohort data.
APACHE II ROC area 5 0.76 (95% CI, 0.71
to 0.81), N 5 292; SAPS II ROC area 5 0.76
(95% CI, 0.71 to 0.82), N 5 292; MPM24 II ROC
area 5 0.84 (95% CI, 0.79 to 0.88), N 5 278.
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Table 6. Calibration and discrimination indexes in the ARF subgroup of patients not referred from an ICU setting, and in the ARF subgroup
of patients who needed renal replacement therapies
ARF patients not referred from an ICU setting ARF patients who needed renal replacement therapies
(N 5 348) (N 5 272)
C test H test ROC area C test H test ROC area
(P value) (P value) (95% C.I.) (P value) (P value) (95% C.I.)
APACHE II 9.66 (0.29) 17.15 (0.03) 0.75 (0.70–0.80) 14.49 (0.07) 21.55 (0.006) 0.72 (0.66 –0.78)
SAPS II 6.2 (0.62) 33.14 (0.0001) 0.75 (0.70–0.81) 5.28 (0.73) 43.35 (0.0001) 0.73 (0.67–0.78)
MPM24 II 14.97 (0.059) 19.42 (0.013) 0.85 (0.80–0.89) 7.12 (0.52) 11.76 (0.16) 0.82 (0.78–0.87)
patient on RRT. Under such clinical circumstances, mor- was considered separately. Similar results were obtained
even in another very important subgroup of ARF pa-tality probability obtained on the day of admission to
the ICU rather than to the nephrology unit (which in tients, that is, those who needed RRT.
Finally, other important factors known to significantlysome cases is many days before ARF diagnosis) indeed
should not be very useful. However, in our study, no influence ARF patient outcome could have impaired the
performance of the models considered, such as: timingrelevant improvement was obtained, especially in the
discrimination capacity, when the models were applied of ARF, time to diagnosis of ARF, time of referral or
lead-time bias, true differences in case mix, pre-existingto the ARF patient subgroup for which they were spe-
cifically designed (that is, after patients transferred from nutritional status, systematic differences in the effective-
ness of treatment, and, finally, modality, dose, and mem-an ICU setting were excluded). Thus, it is unlikely that
our results are seriously biased because of patient trans- brane used for RRT [1, 41, 42].
In our study, the best compromise between calibrationferal from the hospital ICUs to our unit.
Third, the prognostic models applied by us were origi- and discrimination in the ARF cohort and in the ATN
subgroup was obtained with the APACHE II model.nally developed for use in the ICUs, so they should not
be used outside of the ICUs. However, our ARF patients The APACHE II scoring system was developed in
1985 and is based on data from over 5000 patients [26].had a median APACHE II score of 23 (24 in the ATN
subgroup), so they can be considered a group of critically This model is an accurate measure of a patient’s severity
of illness. It strongly correlates with patients’ outcomeill patients independently from the localization in the
hospital. Moreover, there is evidence in the literature and has been validated in several countries. Moreover,
it has been extensively used in the analysis of ARF pa-that prognostic models are reliable instruments even in
intermediate-care unit settings [37]. tients’ prognosis or in the assessment of severity of illness
in this clinical condition [12, 17, 19, 21, 23, 43–45]. How-Fourth, prognostic systems considered in the present
study were developed in general ICUs, where the per- ever, utilization of the APACHE II model in ARF pa-
tients has several shortcomings, which have been thor-centage of patients with ARF is relatively low in compar-
ison with the entire cohort considered for development oughly reviewed elsewhere [3].
When there is evidence that a given general model isand validation. The concept of a critical percentage for
each model variable or condition, above which the pre- not fully appropriate for outcome prediction in a particu-
lar clinical setting, apart from the development of newdictive model deteriorates, was recently stressed in an
elegant model simulation with the MPM II system [38]. models or customization of the existing general models
[38, 39, 46], a possible solution can be represented byFifth, it is well known that a possible cause of poor
performance of a general predictive model can be repre- the use of specialized models. Currently available ARF-
or ATN-specific models have usually been derived fromsented by the presence of subgroups of patients in the
target population for whom the model does not perform single institutions and have been more often used in
specific subsets of ARF patients [9–19], but their valida-well [39, 40]. This can be very relevant when the model is
applied in ICUs that have unique patient characteristics, tion in ARF cohorts from other institutions has given
controversial results (abstracts; Fernandez N et al, J Amsuch as in specialty ICUs.
Sixth, the presumed cause of ARF in the original de- Soc Nephrol 10:A720, 1999; Fiaccadori E et al, J Am Soc
Nephrol 10:A724, 1999).velopment cohorts from the two third-generation models
was ATN, which usually represents more than 90% of Thus, generalizability of these models to the composite
ARF patient cohorts commonly followed in nephrologyparenchymal ARF in the ICUs, but not in other clinical
settings, such as in nephrology wards. Anyway, in our units or in medical wards is still open to discussion.
In conclusion, we have demonstrated that thestudy, in which ATN represented 69% of the cause of
ARF, no major differences were observed in calibration APACHE II model was a slightly better calibrated pre-
dictor of group outcome in both the ARF patient cohortor discrimination of the models when the ATN subgroup
Fiaccadori et al: Outcome prediction in ARF 291
9. Rasmussen H, Pitt E, Ibels L, McNeil D: Prediction of outcomeand in the ATN subgroup, but this model did not provide
in acute renal failure by discriminant analysis of clinical variables.
sufficient confidence for prediction of outcome in indi- Arch Intern Med 145:2015–2018, 1985
10. Lohr J, MacFarlane M, Grantham J: A clinical index to predictvidual patients. MPM24 II model showed the best discrim-
survival in acute renal failure patients requiring dialysis. Am Jination capacity, as compared with both APACHE II
Kidney Dis 11:254–259, 1988
and SAPS II models, but it constantly and significantly 11. Berisa F, Beaman M, Adu D, McGonigle RJ, Michael J, Down-
ing R, Fielding JW, Dunn J: Prognostic factors in acute renaloverestimated the mean predicted mortality in ARF pa-
failure following aortic aneurysm surgery. Q J Med 76:689–698,tients.
1990
We truly need accurate prognostic models in critically 12. Schaefer J, Jochimsen F, Keller F, Wegscheider K, Distler A:
Outcome prediction in acute renal failure in medical intensiveill and particularly in ARF patients, because “human’s
care. Intensive Care Med 17:19–24, 1991ability to make assessment of uncertainty in complicated
13. Groeneweld A, Tran D, van der Meulen J, Nauta J, Thijs L:
situations is poor” [47]. However, it should be equally Acute renal failure in the medical intensive care unit: Predisposing,
complicating factors and outcome. Nephron 59:602–610, 1991stressed that, as recommended in a recent Consensus
14. Barton I, Hilton P, Taub N, Warburton FG, Swan AV, DwightConference [48], a high degree of caution is needed in
J, Mason JC: Acute renal failure treated by haemofiltration: Fac-
the utilization of prognostic models for clinical purposes. tors affecting outcome. Q J Med 86:81–90, 1993
15. Zanardo G, Michielon P, Paccagnella A, Rosi P, Calo´ M,The severity of illness scores, in fact, are not appropriate
Salandin V, Da Ros A, Michieletto F, Simini G: Acute renalfor routine use in clinical decision making nor for making
failure in the patient undergoing cardiac operation: prevalence,
triage decisions. Moreover, they do not take into account mortality rate, and main risk factors. J Thorac Cardiovasc Surg
107:1489–1495, 1994other important factors than mortality, for example,
16. Chertow GM, Christiansen CL, Cleary PD, Munro C, Lazarusmorbidity, disability, and quality of life after discharge.
M: Prognostic stratification in critically ill patients with acute renal
failure requiring dialysis. Arch Intern Med 1505–1511, 1995
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